Leukocytosis
Leukocytosis
Leukocytosis is typically treated with pharmacological interventions such as corticosteroids to reduce inflammation and suppress the immune system. These medications can help alleviate symptoms and address underlying conditions that may be contributing to the elevated white blood cell count.
Read our guide to: Leukocytosis
Leukocytosis
How Leukocytosis Medications Work
Leukocytosis, characterized by an elevated white blood cell count (>10,000 cells/μL), can be effectively managed with pharmacological treatment. The gold standard for treating leukocytosis is corticosteroids, which work by suppressing the immune system's response and reducing inflammation.
- Corticosteroids: These medications inhibit the production of pro-inflammatory cytokines, leading to a decrease in white blood cell count. They also have anti-inflammatory properties, which help reduce swelling and alleviate symptoms associated with leukocytosis.
For patients who do not respond to corticosteroids or require alternative treatments, other options include:
- Immunosuppressive therapy: This type of treatment suppresses the immune system's response, reducing inflammation and white blood cell count.
- Biologics (e.g., TNF-alpha inhibitors): These medications target specific proteins involved in inflammation, reducing symptoms associated with leukocytosis.
- Chemotherapy: In cases of cancer-related leukocytosis, chemotherapy may be used to treat the underlying condition and reduce white blood cell count.